| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | 0.098 | 0.002 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.099 | 0.002 |